RTTNews | Dec 6, 2021 06:12AM EST

06:12 Monday, December 6, 2021 (RTTNews) - Bolt Biotherapeutics Reports Interim BDC-1001 Phase 1/2 Data Shows Well-tolerated Profile And Emerging Clinical Activity

For comments and feedback: contact editorial@rttnews.comCopyright(c) 2021 RTTNews.com. All Rights Reserved